首页> 外国专利> FORECASTING METHOD OF TOXICITY IN PATIENTS WITH BREAST CANCER AFTER CONDUCTING combination chemotherapy with anthracyclines and taxanes by conducting diagnostic studies

FORECASTING METHOD OF TOXICITY IN PATIENTS WITH BREAST CANCER AFTER CONDUCTING combination chemotherapy with anthracyclines and taxanes by conducting diagnostic studies

机译:进行蒽环类药物和紫杉烷类联合化疗后乳腺癌患者中毒的预测方法

摘要

A method of predicting toxicity of patients with breast cancer following chemotherapy combinations of taxanes, and anthracyclines by carrying out diagnostic tests, characterized in that for the prediction of later pankteatoksichnosti (toxic lesions of the pancreas) further evaluate the presence and severity of abdominal pain syndrome, and the results of pancreatic ultrasonograph and the detection of the typical pain and ultrasound signs of acute interstitial changes predict development of late pankreatoksichnosti (toxic damage of the pancreas); for predicting late cardiotoxicity further by echocardiography determined KDOI (index end-diastolic volume, the ratio of end-diastolic volume to body surface area) and the coefficient Ve / Va (ratio trasmitralnogo blood flow in early Ve and late Va left ventricular filling phase) and with increasing index KDOI (end-diastolic volume index) of higher than normal and reducing Ve / Va ratio (ratio of blood flow velocity in trasmitralnogo early (Ve) and late (Va) filling phase lion third ventricle) below normal forecast late cardiotoxicity.
机译:一种通过进行诊断试验来预测紫杉烷和蒽环类药物联合化疗后对乳腺癌患者毒性的方法,其特征在于,为预测以后的胰腺癌(胰腺的毒性病变),进一步评估腹痛综合征的存在和严重程度,胰腺超声检查的结果以及急性间质变化的典型疼痛和超声征兆的检测可预测晚期胰腺癌的发展(胰腺的毒性损伤);用于通过超声心动图进一步预测晚期心脏毒性,确定KDOI(舒张末期容积指数,舒张末期容积与体表面积之比)和系数Ve / Va(早期Ve和晚期Va左心室充盈期的比跨神经节血流)并且增加的KDOI指数(舒张末期容积指数)高于正常水平,并且降低了Ve / Va比(在第三个心室早期(Ve)和晚期(Va)充盈期,第三脑室中trasmitralnogo的血流速度比)低于正常预测的晚期心脏毒性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号